Kellie Rong

Pupil Response & Recovery Rates and Clinical Effects of Low Dose Atropine

Myopia, or near-sightedness, is one of the largest epidemics affecting children and adults worldwide. Atropine has been used as a dilating agent for various clinical purposes, yet at low doses has been found to decrease the progression of myopia in children. This summer, I will be focusing on two projects: 1. Does applying two drops of 0.01% atropine sulfate solution cause the same clinical effects as one drop of 0.02% atropine? 2. How quickly do the pupil responses and ciliary muscles recover following a dose of 0.01% atropine, 0.02% atropine, and 0.05% atropine?

By studying the effects of pupil response and recovery rates at various doses, we are better able to approach the use of atropine as a clinical treatment for myopic children.

Message To Sponsor

I would also like to thank the donors of the URAP summer program who allow students like me to develop and enhance our learning in a laboratory or clinical research setting. The past two semesters have already been very enriching, and it would not be possible to continue this summer without your support!
Profile image of Kellie Rong
Major: Molecular Environmental Biology
Mentor: Sarah Singh/ School of Optometry
Sponsor: Shin-Morgan
Back to Listings
Back to Donor Reports